DL-erythro-Dihydrosphingosine

Overview

DL-erythro-Dihydrosphingosine is a sphingosine-based PKC inhibitor. DL-erythro-Dihydrosphingosine directly inhibits the enzymatic activity of PLA2 . DL-erythro-Dihydrosphingosine inhibits the activity of Bcl-2 protein involved in apoptosis . DL-erythro-Dihydrosphingosine inhibits the activity of matrix metalloproteinases ( MMP ). DL-erythro-Dihydrosphingosine is applicable for research on cancer and inflammatory diseases.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MMP | Products > Signaling Pathways > PKC | Products > Signaling Pathways > Phospholipase | Products > Signaling Pathways > Bcl-2 Family | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-101195
• CAS No.: 3102-56-5
• Molecular Formula: C18H39NO2
• Molecular Weight: 301.52
• Purity: 98%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source